Skip to main content
. Author manuscript; available in PMC: 2023 Apr 21.
Published in final edited form as: Eur J Cell Biol. 2022 Aug 24;101(4):151271. doi: 10.1016/j.ejcb.2022.151271

Fig. 4.

Fig. 4.

A: Co-treatment of TSE-gp120 diminished basal oxygen consumption rate (OCR) in co-treated group when compared with individual treatments and control. B: Reduced mitochondrial membrane potential in TSE-gp120 combination treatment. n = 3 biological replicates/group. *p < 0.05, **p < 0.01, ****p < 0.0001 vs. control; ##p < 0.01, ###p < 0.001, ####p < 0.0001 vs. TS + gp120 co-treatment. n.s. = non statistical significance.